76 related articles for article (PubMed ID: 24276189)
21. Interleukin 1 receptor antagonist polymorphisms are associated with the risk of developing acute coronary syndrome in Mexicans.
Fragoso JM; Delgadillo H; Llorente L; Chuquiure E; Juárez-Cedillo T; Vallejo M; Lima G; Furuzawa-Carballeda J; Peña-Duque MA; Martínez-Ríos MA; Vargas-Alarcón G
Immunol Lett; 2010 Oct; 133(2):106-11. PubMed ID: 20709104
[TBL] [Abstract][Full Text] [Related]
22. Metalloproteinases in diabetics and nondiabetics during acute coronary syndromes and after 3 months.
Derosa G; Cicero AF; Scalise F; Avanzini MA; Tinelli C; Peros E; Fogari E; D'Angelo A
Endothelium; 2007; 14(4-5):175-83. PubMed ID: 17922333
[TBL] [Abstract][Full Text] [Related]
23. Acute respiratory tract infections: a potential trigger for the acute coronary syndrome.
Harskamp RE; van Ginkel MW
Ann Med; 2008; 40(2):121-8. PubMed ID: 18293142
[TBL] [Abstract][Full Text] [Related]
24. The balance of serum matrix metalloproteinase-8 and its tissue inhibitor in acute coronary syndrome and its recurrence.
Pussinen PJ; Sarna S; Puolakkainen M; Öhlin H; Sorsa T; Pesonen E
Int J Cardiol; 2013 Jul; 167(2):362-8. PubMed ID: 22257687
[TBL] [Abstract][Full Text] [Related]
25. The biological role and regulation of matrix metalloproteinases (MMP) in cancer.
Davidson B; Reich R; Risberg B; Nesland JM
Arkh Patol; 2002; 64(3):47-53. PubMed ID: 15338725
[TBL] [Abstract][Full Text] [Related]
26. Positive correlation between CD137 expression and complex stenosis morphology in patients with acute coronary syndromes.
Yan J; Gong J; Liu P; Wang C; Chen G
Clin Chim Acta; 2011 May; 412(11-12):993-8. PubMed ID: 21396356
[TBL] [Abstract][Full Text] [Related]
27. Matrix metalloproteinases: contribution to pathogenesis, diagnosis, surveillance and treatment of abdominal aortic aneurysms.
Kadoglou NP; Liapis CD
Curr Med Res Opin; 2004 Apr; 20(4):419-32. PubMed ID: 15119978
[TBL] [Abstract][Full Text] [Related]
28. [Relation between gene polymorphism and acute coronary syndrome].
Igase M; Miki T
Nihon Rinsho; 2006 Apr; 64(4):647-50. PubMed ID: 16613181
[TBL] [Abstract][Full Text] [Related]
29. The clinical implications of increased cyclophilin A levels in patients with acute coronary syndromes.
Yan J; Zang X; Chen R; Yuan W; Gong J; Wang C; Li Y
Clin Chim Acta; 2012 Apr; 413(7-8):691-5. PubMed ID: 22209965
[TBL] [Abstract][Full Text] [Related]
30. [Features and pathophysiology of acute coronary syndrome].
Bergovec M; Vrazić H; Rajcan Spoljarić I; Raguz M; Stipcević M; Udovicić M
Acta Med Croatica; 2009 Feb; 63(1):3-7. PubMed ID: 19681454
[TBL] [Abstract][Full Text] [Related]
31. Endothelial cell regulation of matrix metalloproteinases.
Haas TL
Can J Physiol Pharmacol; 2005 Jan; 83(1):1-7. PubMed ID: 15759044
[TBL] [Abstract][Full Text] [Related]
32. [Matrix metalloproteinases and atherosclerosis. Therapeutic aspects].
Beaudeux JL; Giral P; Bruckert E; Foglietti MJ; Chapman MJ
Ann Biol Clin (Paris); 2003; 61(2):147-58. PubMed ID: 12702469
[TBL] [Abstract][Full Text] [Related]
33. Relation between upregulation of CD40 system and complex stenosis morphology in patients with acute coronary syndrome.
Yan JC; Wu ZG; Kong XT; Zong RQ; Zhan LZ
Acta Pharmacol Sin; 2004 Feb; 25(2):251-6. PubMed ID: 14769218
[TBL] [Abstract][Full Text] [Related]
34. Interaction between endothelial nitric oxide synthase gene polymorphisms (-786T>C, 894G>T and intron 4 a/b) and cardiovascular risk factors in acute coronary syndromes.
da Costa Escobar Piccoli J; Manfredini V; Hamester FI; Bandinelli JB; Turkienicz IM; Chies JA; Peres A; Bodanese LC; Bogo MR
Arch Med Res; 2012 Apr; 43(3):205-11. PubMed ID: 22475779
[TBL] [Abstract][Full Text] [Related]
35. Genetic analysis of MMP gene polymorphisms in patients with Kawasaki disease.
Ikeda K; Ihara K; Yamaguchi K; Muneuchi J; Ohno T; Mizuno Y; Hara T
Pediatr Res; 2008 Feb; 63(2):182-5. PubMed ID: 18091353
[TBL] [Abstract][Full Text] [Related]
36. Genotype-phenotype association of matrix metalloproteinase-3 polymorphism and its synergistic effect with smoking on the occurrence of acute coronary syndrome.
Liu PY; Li YH; Chan SH; Lin LJ; Wu HL; Shi GY; Chen JH
Am J Cardiol; 2006 Oct; 98(8):1012-7. PubMed ID: 17027562
[TBL] [Abstract][Full Text] [Related]
37. Plaque image characteristics, hyperhomocysteinemia, and gene polymorphism of homocysteine metabolism-related enzyme (MTHFR C677T) in acute coronary syndrome.
Xu H; Liu C; Wang Q
Cell Biochem Biophys; 2013 Jun; 66(2):403-7. PubMed ID: 23314883
[TBL] [Abstract][Full Text] [Related]
38. Matrix metalloproteinases in premature coronary atherosclerosis: influence of inhibitors, inflammation, and genetic polymorphisms.
Nanni S; Melandri G; Hanemaaijer R; Cervi V; Tomasi L; Altimari A; Van Lent N; Tricoci P; Bacchi L; Branzi A
Transl Res; 2007 Mar; 149(3):137-44. PubMed ID: 17320799
[TBL] [Abstract][Full Text] [Related]
39. [The frequency of allelic polymorphism of matrix Gla-protein gene in acute coronary syndrome patients].
Harbuzova VIu; Hur'ianova VL; Parkhomenko OM; Dosenko VIe; Ataman OV
Fiziol Zh (1994); 2011; 57(3):16-24. PubMed ID: 21870514
[TBL] [Abstract][Full Text] [Related]
40. [Extracellular matrix -- from basic research to clinical significance. An overview with special consideration of matrix metalloproteinases].
Hamacher S; Matern S; Roeb E
Dtsch Med Wochenschr; 2004 Sep; 129(38):1976-80. PubMed ID: 15375740
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
